.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
US Army
Queensland Health
QuintilesIMS
Express Scripts
Federal Trade Commission
Chinese Patent Office
US Department of Justice
Moodys
Cipla

Generated: June 25, 2017

DrugPatentWatch Database Preview

TIROSINT Drug Profile

« Back to Dashboard

What is the patent landscape for Tirosint, and when can generic versions of Tirosint launch?

Tirosint is a drug marketed by Institut Biochimique and is included in three NDAs. There are two patents protecting this drug.

This drug has sixteen patent family members in nine countries.

The generic ingredient in TIROSINT is levothyroxine sodium. There are ten drug master file entries for this compound. Forty-two suppliers are listed for this compound. Additional details are available on the levothyroxine sodium profile page.

Summary for Tradename: TIROSINT

Patents:2
Applicants:1
NDAs:3
Suppliers / Packagers: see list1
Bulk Api Vendors: see list37
Clinical Trials: see list4
Patent Applications: see list6,769
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TIROSINT at DailyMed

Pharmacology for Tradename: TIROSINT

Ingredient-typeThyroxine
Drug Classl-Thyroxine
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Institut Biochimique
TIROSINT-SOL
levothyroxine sodium
SOLUTION;ORAL206977-009Dec 15, 2016RXYesNo► Subscribe► Subscribe
Institut Biochimique
TIROSINT-SOL
levothyroxine sodium
SOLUTION;ORAL206977-010Dec 15, 2016RXYesNo► Subscribe► Subscribe
Institut Biochimique
TIROSINT
levothyroxine sodium
CAPSULE;ORAL022121-001Aug 1, 2007RXNoNo7,723,390► SubscribeY ► Subscribe
Institut Biochimique
TIROSINT
levothyroxine sodium
CAPSULE;ORAL021924-007Oct 13, 2006RXYesYes7,723,390► SubscribeY ► Subscribe
Institut Biochimique
TIROSINT-SOL
levothyroxine sodium
SOLUTION;ORAL206977-005Dec 15, 2016RXYesNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: TIROSINT

Country Document Number Estimated Expiration
European Patent Office1291021► Subscribe
Japan5105685► Subscribe
Japan4851064► Subscribe
Japan2003081870► Subscribe
Germany60329968► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Cantor Fitzgerald
Mallinckrodt
Federal Trade Commission
US Army
Daiichi Sankyo
Covington
Fish and Richardson
Chubb
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot